Completed
A randomized control clinical trial of micronutrient and antioxidant supplementation in persons with untreated HIV infection
Learn MoreCompleted
A tri-national (Canada, UK, USA) randomized, controlled trial to determine the optimal management of patients with HIV infection for whom first and second-line highly active antiretroviral therapy has failed
Learn MoreEnrolling
Vedolizumab treatment in antiretroviral drug treated chronic HIV infection, followed by analytical treatment interruption (HIV-ART-vedolizumab-ATI)
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
